Shares of Baxter International Inc. rallied 5.45% to $21.87 Wednesday, on what proved to be an all-around great trading ...

Baxter International Inc. (NYSE:BAX) shares tumbled 14% after the global medtech leader reported fourth-quarter earnings that missed analyst expectations and issued disappointing profit guidance for ...

Pzena Investment Management recently released its fourth-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The fourth quarter was defined by ...

Baxter International Inc. BAX is scheduled to release fourth-quarter 2025 results on Feb. 12, before the opening bell. In the ...

Baxter International Inc (BAX) reports robust sales growth in Q4 2025, but faces challenges with declining margins and operational hurdles.

Kirby McInerney LLP reminds Baxter International, Inc. (“Baxter” or the “Company”) (NYSE:BAX) investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a pending federal ...

On April 7, 2025, a Missouri news outlet reported serious safety issues relating to inaccurate infusion rates with Baxter’s Novum IQ Large Volume Pump (“Novum LVP”), a device used for the controlled ...

NEW YORK, Nov. 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). Shareholders who purchased shares of BAX during the ...

Establishes Vantive as a leading standalone kidney care business backed by Carlyle’s global investment team and resources Sale follows robust process focused on maximizing stockholder value Provides ...

Baxter, headquartered in Deerfield, Illinois, develops, manufactures, and markets medical products used in the healthcare industry. The Company recently launched the Novum LVP, a device that controls ...

We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will summarize the bulls’ thesis on BAX. Baxter International Inc.’s share was trading ...